|
Pemetrexed Plus Cisplatin Has "Remarkable" Results in Mesothelioma
Mardi 07 Octobre 2008 - 05:57 - 6 jours, 10 heures depuis - Presse spécialisée - Medscape hematology oncology Results of 2 phase 3 trials indicate that combination therapy significantly prolongs survival in mesothelioma. Medscape Medical News |
|
Black Patients Have Poorer Survival in Head and Neck Cancer
Lundi 06 Octobre 2008 - 11:00 - 1 semaine depuis - Presse spécialisée - Medscape hematology oncology A new analysis shows that race and socioeconomic status have a significant affect on patient survival in head and neck cancer, even after adjustment for other factors Medscape Medical News |
|
Scientists Discover Neuroblastoma Gene
Lundi 06 Octobre 2008 - 10:39 - 1 semaine depuis - Presse spécialisée - Medscape hematology oncology The author discusses new findings about a genetic cause of neuroblastoma. Medscape Genomic Medicine |
|
New Finding May Improve Diagnosis of Juvenile Leukemia
Lundi 06 Octobre 2008 - 09:59 - 1 semaine depuis - Presse spécialisée - Medscape hematology oncology An abnormal signaling pathway that appears to be highly specific to juvenile myelomonocytic leukemia could allow for more rapid and accurate diagnosis and targeted therapies. Medscape Medical News |
|
Let's Not Give Up on Dual Antibodies in Colon Cancer...Yet
Samedi 04 Octobre 2008 - 19:28 - 1 semaine, 1 jour depuis - Presse spécialisée - Medscape hematology oncology In this video blog, Dr. John Marshall observes that despite unexpected negative results in the PACCE and CAIRO2 trials, dual antibody therapy may yet play a role in colorectal cancer. Medscape Hematology-Oncology |
|
The Astute Clinician: Filing High-Value Adverse Drug Event Reports
Vendredi 03 Octobre 2008 - 09:00 - 1 semaine, 3 jours depuis - Presse spécialisée - Medscape hematology oncology What information should you include in an ADE report? How is that information used? Medscape Pharmacists |
|
Baroreflex Failure Linked to Radiation for Head and Neck Cancer
Vendredi 03 Octobre 2008 - 08:49 - 1 semaine, 3 jours depuis - Presse spécialisée - Medscape hematology oncology Baroreflex failure following chemotherapy is an underrecognized cause of labile blood pressures, resulting in hypertension, orthostatic hypotension, and syncope, researchers warn. Medscape Medical News |
|
Is Gastric Cancer Survival Improved By Adding Para-Aortic Nodal Dissection to D2 Lymphadenectomy?
Vendredi 03 Octobre 2008 - 08:31 - 1 semaine, 3 jours depuis - Presse spécialisée - Medscape hematology oncology Commentary on a study on whether extended lymphadenectomy improves survival in patients with gastric cancer, published July 2008 in The New England Journal of Medicine. Medscape General Surgery |
|
Research Into Colorectal Cancer Uncovers Early Clues
Vendredi 03 Octobre 2008 - 06:24 - 1 semaine, 3 jours depuis - Presse spécialisée - Medscape hematology oncology Researchers believe a molecule abnormally found in the colon might be a key to colorectal cancer development; another study reveals the first genetic link between obesity and this cancer. Medscape Medical News |
|
Doing Better for Less: The Case for Organized Group Practices
Vendredi 03 Octobre 2008 - 05:49 - 1 semaine, 3 jours depuis - Presse spécialisée - Medscape hematology oncology Shannon Brownlee, MS, Visiting Scholar, National Institutes of Health, Washington, DC, explains how to both cut healthcare costs and improve quality. The Medscape Journal of Medicine |
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8 – 9 – 10 – 11 – 12 – 13 – 14 – 15 – 16 – 17 – 18 – 19 – 20 – 21 – 22 – 23 – 24 – 25 – 26 – 27 >
Actus fournies par : Medscape Hematology-Oncology Headlines